Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 10.71%

Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has an Asset Resilience Ratio of 10.71% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 603392 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.54 Billion

≈ $225.16 Million USD Cash + Short-term Investments

Total Assets

CN¥14.37 Billion

≈ $2.10 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Asset Resilience Ratio has changed over time. See 603392 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Beijing Wantai Biological Pharmacy Enterprise Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Beijing Wantai Biological Pharmacy Enter.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.54 Billion	10.71%
Total Liquid Assets	CN¥1.54 Billion	10.71%

Asset Resilience Insights

Moderate Liquidity: Beijing Wantai Biological Pharmacy Enterprise Co Ltd has 10.71% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Wantai Biological Pharmacy Enterprise Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Argen-X F:1AE	Biotechnology	25.67%
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	Biotechnology	0.21%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.48%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	70.49%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%

Annual Asset Resilience Ratio for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing Wantai Biological Pharmacy Enterprise Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.09%	CN¥2.51 Billion ≈ $367.30 Million	CN¥14.69 Billion ≈ $2.15 Billion	+1.46pp
2023-12-31	15.62%	CN¥2.46 Billion ≈ $359.30 Million	CN¥15.71 Billion ≈ $2.30 Billion	+3.25pp
2022-12-31	12.38%	CN¥2.01 Billion ≈ $293.92 Million	CN¥16.23 Billion ≈ $2.37 Billion	+11.80pp
2021-12-31	0.57%	CN¥40.39 Million ≈ $5.91 Million	CN¥7.05 Billion ≈ $1.03 Billion	-0.86pp
2020-12-31	1.44%	CN¥50.36 Million ≈ $7.37 Million	CN¥3.50 Billion ≈ $512.70 Million	-1.24pp
2019-12-31	2.68%	CN¥58.00 Million ≈ $8.49 Million	CN¥2.16 Billion ≈ $316.80 Million	+2.66pp
2018-12-31	0.02%	CN¥343.70K ≈ $50.29K	CN¥1.81 Billion ≈ $265.54 Million	-0.02pp
2017-12-31	0.04%	CN¥671.42K ≈ $98.25K	CN¥1.66 Billion ≈ $242.29 Million	0.00pp
2016-12-31	0.04%	CN¥619.72K ≈ $90.68K	CN¥1.45 Billion ≈ $212.83 Million	+0.02pp
2015-12-31	0.03%	CN¥301.31K ≈ $44.09K	CN¥1.10 Billion ≈ $161.20 Million	+0.02pp
2014-12-31	0.01%	CN¥64.47K ≈ $9.43K	CN¥805.50 Million ≈ $117.87 Million	-0.01pp
2013-12-31	0.02%	CN¥121.71K ≈ $17.81K	CN¥606.98 Million ≈ $88.82 Million	--

pp = percentage points

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$7.27 Billion

CN¥49.69 Billion CNY

Market Cap Rank

#2789 Global

#357 in China

Share Price

CN¥39.30

Change (1 day)

+0.59%

52-Week Range

CN¥37.95 - CN¥78.36

All Time High

CN¥142.90